196 related articles for article (PubMed ID: 18664389)
1. Brucella: a Mr "Hide" converted into Dr Jekyll.
Gorvel JP
Microbes Infect; 2008 Jul; 10(9):1010-3. PubMed ID: 18664389
[TBL] [Abstract][Full Text] [Related]
2. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
[TBL] [Abstract][Full Text] [Related]
3. Towards a Brucella vaccine for humans.
Perkins SD; Smither SJ; Atkins HS
FEMS Microbiol Rev; 2010 May; 34(3):379-94. PubMed ID: 20180858
[TBL] [Abstract][Full Text] [Related]
4. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
5. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
6. Duplex PCR for differentiation of the vaccine strain Brucella suis S2 and B. suis biovar 1 from other strains of Brucella spp.
Nan W; Tan P; Wang Y; Xu Z; Mao K; Peng D; Chen Y
Vet J; 2014 Sep; 201(3):427-8. PubMed ID: 25011712
[TBL] [Abstract][Full Text] [Related]
7. [Placental infection of mice by Brucella. Pathogenicity and immunity].
Bosseray N
Dev Biol Stand; 1984; 56():283-93. PubMed ID: 6436097
[No Abstract] [Full Text] [Related]
8. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis.
Billard E; Cazevieille C; Dornand J; Gross A
Infect Immun; 2005 Dec; 73(12):8418-24. PubMed ID: 16299342
[TBL] [Abstract][Full Text] [Related]
9. Advancement of knowledge of Brucella over the past 50 years.
Olsen SC; Palmer MV
Vet Pathol; 2014 Nov; 51(6):1076-89. PubMed ID: 24981716
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
12. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
Bascoul S; Cannat A; Huguet MF; Serre A
Immunology; 1978 Aug; 35(2):213-21. PubMed ID: 750371
[TBL] [Abstract][Full Text] [Related]
13. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
[TBL] [Abstract][Full Text] [Related]
14. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.
Kahl-McDonagh MM; Ficht TA
Infect Immun; 2006 Jul; 74(7):4048-57. PubMed ID: 16790778
[TBL] [Abstract][Full Text] [Related]
16. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
17. Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model.
Surendran N; Zimmerman K; Seleem MN; Sriranganathan N; Boyle SM; Hiltbold EM; Lawler H; Heid B; Witonsky SG
Vaccine; 2010 Oct; 28(43):7009-15. PubMed ID: 20727395
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
Al-Mariri A; Abbady AQ
J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
[TBL] [Abstract][Full Text] [Related]
19. Selection of a Brucella vaccine strain of low residual virulence by chemical mutagenesis.
Zhao WR; Wendoso ; Hasi ; Qin YX; Weng W; Lu SL
J Med Microbiol; 1989 Oct; 30(2):143-8. PubMed ID: 2795638
[TBL] [Abstract][Full Text] [Related]
20. Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics.
He Y
Front Cell Infect Microbiol; 2012; 2():2. PubMed ID: 22919594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
